logo-loader
Pivot Pharmaceuticals

Pivot Pharmaceutical sign Letter of Intent for controlling interest in iAmHealth

Pivot Pharmaceuticals (CSE: PVOT-OTC-PVOTF) President Russell Starr sat down with Steve Darling from Proactive Vancouver to discuss their company that plays in the cannabis. Starr is discussing how the company has changed including their very influential leaders. 

Starr also told Proactive about their current sales in Europe and when they will be in Canada and the U.S. with a number of different lines including pets and sexual health. Starr also shares details about a new deal they just signed with iAmHealth.

Quick facts: Pivot Pharmaceuticals

Price: $0.30

Market: CSE
Market Cap: $51.31 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

hVIVO PLC's 2020 pipeline 'looking strong' as it expands service offerings

hVIVO PLC's (LON:HVO) executive chairman Trevor Phillips tells Proactive London's Andrew Scott the business is now better positioned to be profitable next year. The creator of pioneering human disease models based upon viral challenge generated revenues of £5.9mln in the six months ended June...

12 hours, 17 minutes ago

2 min read

;